RAD18 and central nervous system cancer: Having been able to rescue glioma cells from the TMZ/MS-275 induced S-phase accumulation by overexpressing RAD18-GFP, we conclude that RAD18 is required for bypassing TMZ-induced O6MeG MMR intermediates in S-phase.